Tennessee 2023-2024 Regular Session

Tennessee Senate Bill SB2385

Introduced
1/30/24  

Caption

AN ACT to amend Tennessee Code Annotated, Title 37; Title 49; Title 63; Title 68 and Title 71, relative to blood lead level testing.

Impact

The implications of SB2385 are significant for state laws regarding public health and education. By requiring blood lead testing, the bill aligns with broader public health initiatives aimed at preventing lead poisoning in children, promoting better health outcomes, and ensuring that affected children receive necessary supports. Additionally, it extends similar testing requirements to pregnant women receiving special food program vouchers, thereby protecting maternal and fetal health. This comprehensive approach seeks to mitigate the risks associated with lead exposure at critical stages of development.

Summary

Senate Bill 2385 aims to amend various sections of the Tennessee Code Annotated related to blood lead level testing, specifically targeting children before their enrollment in public schooling from pre-kindergarten through grade twelve (pre-K-12). The bill mandates the Department of Health to ensure blood lead level testing is accessible and required for these children. Furthermore, it obligates parents or guardians to have their children tested and provides a pathway for addressing potential lead poisoning through educational services under the Individuals with Disabilities Education Act if elevated lead levels are detected.

Sentiment

The discussions surrounding SB2385 reflected a supportive sentiment from a range of health advocates and educators who view the bill as a crucial step towards improving child health standards in Tennessee. Proponents advocate that early testing can lead to early interventions, potentially reducing the adverse effects of lead exposure. However, some concerns may arise regarding the practicality of implementing such mandates at schools and the adequacy of resources to support the required wrap-around services for affected children.

Contention

Notably, opponents may argue about the feasibility of mandating such tests and how it could affect parental rights, given that parents have the option to opt-out. Critics might raise concerns over the financial and institutional implications these combined requirements could impose on schools and health systems, especially regarding the challenge of addressing educational services for children identified with elevated lead levels. The discussion also highlights a broader debate on how best to balance health regulations and parental autonomy in child-rearing.

Companion Bills

TN HB2655

Crossfiled AN ACT to amend Tennessee Code Annotated, Title 37; Title 49; Title 63; Title 68 and Title 71, relative to blood lead level testing.

Previously Filed As

TN HB2655

AN ACT to amend Tennessee Code Annotated, Title 37; Title 49; Title 63; Title 68 and Title 71, relative to blood lead level testing.

TN HB1369

AN ACT to amend Tennessee Code Annotated, Title 37; Title 49; Title 63; Title 68 and Title 71, relative to blood lead level testing.

TN SB1255

AN ACT to amend Tennessee Code Annotated, Title 37; Title 49; Title 63; Title 68 and Title 71, relative to blood lead level testing.

TN HB0571

AN ACT to amend Tennessee Code Annotated, Title 4; Title 37; Title 41; Title 49 and Title 68, relative to public safety.

TN SB0468

AN ACT to amend Tennessee Code Annotated, Title 4; Title 37; Title 41; Title 49 and Title 68, relative to public safety.

TN SB1170

AN ACT to amend Tennessee Code Annotated, Title 4; Title 33; Title 49; Title 53; Title 55; Title 56; Title 63; Title 68 and Title 71, relative to healthcare professions.

TN HB2936

AN ACT to amend Tennessee Code Annotated, Title 33; Title 36; Title 37; Title 49; Title 63 and Title 68, relative to families' rights and responsibilities.

TN SB2749

AN ACT to amend Tennessee Code Annotated, Title 33; Title 36; Title 37; Title 49; Title 63 and Title 68, relative to families' rights and responsibilities.

TN HB0070

AN ACT to amend Tennessee Code Annotated, Title 56; Title 63; Title 68 and Title 71, relative to coverage of biomarker testing for preeclampsia.

TN SB0205

AN ACT to amend Tennessee Code Annotated, Title 56; Title 63; Title 68 and Title 71, relative to coverage of biomarker testing for preeclampsia.

Similar Bills

No similar bills found.